期刊文献+

The effects of Chinese Yam-Epimedium mixture on respiratory function and quality of life in patients with chronic obstructive pulmonary disease 被引量:11

The effects of Chinese Yam-Epimedium mixture on respiratory function and quality of life in patients with chronic obstructive pulmonary disease
原文传递
导出
摘要 OBJECTIVE:To examine the clinical effects of a mixture of Chinese Yam and Epimedium in patients with stable moderate or severe chronic obstructive pulmonary disease(COPD).METHODS:Forty-nine patients with COPD were randomly allocated to a group whose usual treatment was supplemented with oral Chinese Yam-Epimedium mixture,or a control group given placebo.For each patient,body mass index,airflow obstruction,dyspnea,and exercise capacity were measured and converted into the BODE index before treatment and at one and three months after initiation of treatment.Participants also completed the St George's Respiratory Questionnaire(SGRQ) at the same intervals.RESULTS:After one month,improvements were seen in the BODE index and SGRQ of participants taking Chinese Yam-Epimedium mixture compared to controls.There were statistically significant differences in the SGRQ:three of its components and the total SGRQ scores were significantly decreased(P<0.05),respiratory symptom scores had improved(P<0.01),and the dyspnea component of the BODE index had significantly decreased(P<0.05).Similar improvements were observed after three months of treatment,but exercise tolerance had also improved:the six-minute walking distance had significantly increased(P<0.05) in the treatment group when compared with controls.CONCLUSION:Chinese Yam-Epimedium mixture can significantly improve dyspnea,exercise capacity,and the quality of life of patients with stable moderate or severe COPD. OBJECTIVE:To examine the clinical effects of a mixture of Chinese Yam and Epimedium in patients with stable moderate or severe chronic obstructive pulmonary disease(COPD).METHODS:Forty-nine patients with COPD were randomly allocated to a group whose usual treatment was supplemented with oral Chinese Yam-Epimedium mixture,or a control group given placebo.For each patient,body mass index,airflow obstruction,dyspnea,and exercise capacity were measured and converted into the BODE index before treatment and at one and three months after initiation of treatment.Participants also completed the St George's Respiratory Questionnaire(SGRQ) at the same intervals.RESULTS:After one month,improvements were seen in the BODE index and SGRQ of participants taking Chinese Yam-Epimedium mixture compared to controls.There were statistically significant differences in the SGRQ:three of its components and the total SGRQ scores were significantly decreased(P〈0.05),respiratory symptom scores had improved(P〈0.01),and the dyspnea component of the BODE index had significantly decreased(P〈0.05).Similar improvements were observed after three months of treatment,but exercise tolerance had also improved:the six-minute walking distance had significantly increased(P〈0.05) in the treatment group when compared with controls.CONCLUSION:Chinese Yam-Epimedium mixture can significantly improve dyspnea,exercise capacity,and the quality of life of patients with stable moderate or severe COPD.
出处 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2012年第2期203-207,共5页 中医杂志(英文版)
关键词 Pulmonary disease Obstructive Chinese herbal drug BODE index(the body-mass index airflow obstruction DYSPNEA and exercise capacity index) The St George's respiratory questionnaire(SGRQ) Quality of life 慢性阻塞性肺病 呼吸功能 生活质量 混合物 淫羊藿 中国 患者 山药
  • 相关文献

参考文献6

  • 1Zhu YJ;Chen WB.Respiratory medicine(the first edition)[M]北京:人民卫生出版社,2003877-892.
  • 2Zhao YL,Fei JX,Liu QP,Shen LY. The effects of uptake of different does of casein combined with Chinese herbal drugs on diaphragm function in rats with emphysema[J].Journal of Hygiene Research,2011.162-163.
  • 3Society of Chronic Obstructive Pulmonary Disease,Branch Association of Respiratory Disease,Chinese Medical Association. Guide to diagnosis and treatment of chronic obstructive pulmonary disease (revision,2007)[J].Chinese J of Tuberculosis and Respiratory Diseases,2007.8-17.
  • 4Good Clinical Practice. Issued by State Food and Drug Administration[M].PRC in September 1,1999.
  • 5Celli BR,Cote CG,Matin JM,Casanova C Montes de Oca M Mendez RA Pinto Plata V Cabral HJ. The body-mass index,airflow obstruction,dyspnea,and exercise capacity index in chronic obstructive pulmonary disease[J].New England Journal of Medicine,2004.1005-1012.
  • 6Mahler DA,Wells CK. Evaluation of clinical methods for rating dyspnea[J].Chest,1988.580-586.

同被引文献74

引证文献11

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部